Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 11:33 AM UTC
| NCT Number | NCT07660055 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 156 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 27, 2026 (5 days ago) |
As of September 1, 2026: Clinical trial NCT07660055 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07660055 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07660055 was last updated 5 days ago (August 27, 2026). HelloStudys verifies this status automatically.